Xianjue Bio's microphysiological models unlock new possibilities for multi-scenario biomimetic research

In organoid and organ-on-a-chip research, the demands of experimental systems vary greatly depending on different disease models and research objectives—cancer research requires simulating disordered vascular networks, normal organ modeling needs to restore physiological vascular structures, and drug screening relies on precise and controllable gel microenvironments. Traditional microphysiological models often have fixed structures, making them difficult to adapt to diverse research needs, frequently leaving researchers in the predicament of 'the model cannot fit the experiment'.

Xianjue Bio's vascularized microphysiological models, with the core advantage of 'self-replaceable vascular structures and gel compositions,' break through the rigid limitations of traditional models, providing highly flexible biomimetic solutions for precision medicine and innovative drug development, ensuring experimental systems precisely match research needs!
Flexibly Replace Vascular Structures: Precisely Replicate Different Physiological/Pathological States
Vascular networks are the core support for organ function, and vascular structures differ significantly across organs and disease stages. Xianjue Bio's microphysiological models support on-demand replacement of vascular structures, completely freeing you from the constraint of 'one model for everything'.

• For Cancer Research: Can construct disordered, easily degenerating tumor vascular structures, precisely simulating the pathological characteristics of 'higher tumor density, more pronounced vascular degeneration' in solid tumors like lung and liver cancer, providing a realistic model for tumor microenvironment research and anti-angiogenic drug screening;
• For Normal Organ Modeling: Can construct functional vascular networks that conform to human developmental characteristics, enabling continuous nutrient supply and metabolic waste removal, supporting long-term stable culture of organoids for normal organs such as the brain, heart, and liver (vascular network survival exceeding 21 days);
• For Special Research Needs: Through the cross-scale integration of 3D bioprinting and microfluidic chips, customizable vascular structures with different branching densities and perfusion channels can be created, adapting to all-scenario needs from basic research to drug development. Freely Switch Gel Compositions: Precisely Control Cell Microenvironment Extracellular matrix gel is the 'soil' for organoid growth; its composition, stiffness, and bioactivity directly affect the model's biomimicry and experimental reliability. Xianjue Bio's microphysiological models support flexible gel composition replacement, paired with our self-developed biomimetic extracellular matrix gels, to achieve precise microenvironment control.
• Safe and Controllable Composition: Optional animal-free synthetic gels with clear, residue-free components avoid biosafety risks and ensure stable experimental data;
• Functionality Adapted to Needs: Gels with sustained release of cytokines or tunable mechanical properties can be selected to suit different applications such as organoid culture, 3D vascularization, and tumor organoid vascularization;
• Efficient and Convenient Operation: Paired with Xianjue Bio's 5-minute rapid gelation products, which offer excellent transparency and are compatible with imaging, experimental systems can be quickly established without complex procedures. Multi-Scenario Adaptation + Core Technology Support = Multiplied Value

In addition to the flexible advantage of 'replaceability,' Xianjue Bio's microphysiological models rely on the integrated core technologies of 'vascularization + immune microenvironment + AI closed-loop' to achieve both flexible customization and high biomimicry and reliability:

• High Biomimetic Restoration: Replaced vascular structures and gel compositions can precisely replicate human physiological or pathological states. For example, in lung cancer organoid vascularization models, the interaction between tumors and blood vessels closely matches clinical reality;
• Full-Process Compatibility: Seamlessly integrates with automated equipment such as visualization three-gas regulation incubators and digital dynamic algorithm analysis microscopes, enabling 'culture → imaging → analysis → regulation' automation;
• Multi-Terminal Applications: Adapts to three major scenarios: individualized precision drug sensitivity testing in hospitals, complex pathological model construction in research institutions, and preclinical drug screening for pharmaceutical companies, providing customized solutions for different users.

Under the national strategic focus on 'organoids and artificial organs,' Xianjue Bio, with its core advantage of 'self-replaceable vascular structures and gel compositions,' breaks through the application limitations of traditional models, allowing every research project to have its own exclusive, highly biomimetic microphysiological model. Whether for tumor microenvironment mechanism research, innovative drug screening, or individualized precision medicine exploration, Xianjue Bio can provide flexible, precise, and reliable technical support to facilitate research breakthroughs and clinical translation!